Clinical Trial Update: Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atezolizumab given concurrently with radiotherapy in patients with muscle-invasive bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Spanish Oncology Genito-Urinary Group | Conditions: Bladder Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING